Chris has been actively investing in healthcare since 2000. He specializes in healthcare investments in the medical device, health technology, diagnostics and services sectors. During his investment career, he has served on over forty boards of directors and has overseen the deployment of $950 million in equity capital in healthcare companies during that time. Prior to the development of Cadence Healthcare Ventures, Chris was the Founder and CEO of Alhambra Medical, Inc. and 33 BioMedical, Inc. These companies were established in partnership with Boston Scientific and raised $10 million of financing to develop products in the peripheral vascular and interventional oncology space. Prior to this, Chris was recruited to establish Boston Scientific Ventures, a fully discretionary fund, which he led from January 2012 to September
of 2019.

During this period, Chris led financings in forty-five companies from seed to commercial stage opportunities and deployed $780 million. Previously, Chris was a General Partner at Medventure Associates from 2003 to 2012. In addition, Chris was previously a Senior Research Analyst with WR Hambrecht + Co., covering the medical device and diagnostic sectors, previously coming from Piper Jaffray.